News

Newsletter

BPTO: PPH Limit for Telecommunications Applications Reached for the Second Quarter of 2025

The BPTO announced on its website that the limit of 140 PPH requests for the second quarter of 2025, referring to patent applications with main IPC H04 (telecommunications cases), has already been reached. Such limit has been reached only 2 days after the acceptance of new requests for the second quarter, which shows how important the PPH program is for applications in the technical field of telecommunications.

We are proud to share that Kasznar Leonardos was responsible for 40 of these PPH requests, successfully filed on April 1, 2025. This amount represents 28.57% of the request limit allowed by the BPTO.

The expressive performance of our team reinforces the firm’s commitment to agility and excellence in protecting our clients’ inventions.

For the third quarter of 2025, BPTO is expected to announce a new limit for PPH requests for telecommunications cases.

It is worth remembering that PPH requests for patent applications in other technical areas may still be filed in Brazil.

For further information, please do not hesitate to contact our team at mail@kasznarleonardos.com.

Back

Last related news

9 de December de 2025

Fake Software Resellers: A Growing Risk for Users and a New Front in IP Enforcement

For years, the most common form of software piracy involved downloading cracked or unauthorized versions from websites offering them for free. Although Fake Software Resellers: A Growing Risk for Users and a New Front in IP Enforcement

  • Kasznar Leonardos
  • Ler notícia

    25 de November de 2025

    Significant Win for Kasznar Leonardos as Appellate Court Raises Compensation in Software Infringement Case

    Kasznar Leonardos is pleased to announce an important victory before the São Paulo Court of Appeals in a software license compliance action Significant Win for Kasznar Leonardos as Appellate Court Raises Compensation in Software Infringement Case

  • Kasznar Leonardos
  • Ler notícia

    13 de November de 2025

    ANVISA Publishes Exceptional Rule to Expedite Analysis of Medicines and Biological Products

    The National Health Surveillance Agency (Anvisa) published on Monday, November 10, 2025, the Collegiate Board Resolution (RDC) No. 997/2025, which institutes exceptional ANVISA Publishes Exceptional Rule to Expedite Analysis of Medicines and Biological Products

  • Kasznar Leonardos
  • Ler notícia